5 analysts have expressed a variety of opinions on Adaptive Biotechnologies (NASDAQ:ADPT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Range Biotechnologies – a proteomics-focused biotech company that has developed an innovative translational platform to enable better diagnostics and faster drug development – announced recently that ...

Adaptive Biotechnologies (NASDAQ:ADPT) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of ...

Cell engineering platform company Portal Biotechnologies announced a $5 million pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. Armon Sharei, Ph.D., the founder ...

Offers immunosequencing platforms (immunoSEQ), clinical diagnostics (clonoSEQ, T-Detect), and research tools for immune system profiling, with revenue primarily generated from product sales and ...

View Adaptive Biotechnologies Corp. ADPT stock quote prices, financial information, real-time forecasts, and company news from CNN.

Adaptive Biotechnologies (ADPT) shares ended the last trading session 5.8% higher at $13.17. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...